Illustration: Aïda Amer/Axios
Sponsors and strategics are circling the rest of primary care company Cano Health's (NYSE: CANO) assets, two sources familiar tell Axios.
Why it matters: The company got a needed lifeline from a recent sale, but its breakup is not done yet.
